In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ ... Investors looking for promising yet lower-priced stocks, particularly those trading under $20, may find ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted ... guilty today to a federal securities fraud count for insider trading. George Demos, 64, formerly of Acadia Pharmaceuticals ...

The former vice president of a Carmel Valley pharmaceutical company pleaded guilty Friday to a federal securities fraud count.

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted to insider trading for selling more than 60,000 Acadia shares just before news broke regarding an issue with one of the company ...

Editor’s note: This story has been updated to correct the individual who admitted to insider trading. SAN DIEGO (FOX 5/KUSI) — The former vice president of Acadia Pharmaceuticals Inc ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

The former vice president of a San Diego-based pharmaceutical company pleaded guilty Friday to a federal securities fraud count for insider trading ... 64, formerly of Acadia Pharmaceuticals ...